Hacker News new | past | comments | ask | show | jobs | submit login

Purdue pharma knew that their drug was more addictive that what was reported by the FDA, and chose to keep distributing it and pushing doctors to recommend it to people who didn't need it instead of re-doing the evaluation.

I did mention that they were not upfront about the risks. This is definitely not OK, but it is still only one of the factors.

Now, as far as pushing it to doctors: That's not an issue that is unique to this drug or this drug company. It is generally more referred to as an off-label use, which has its good and bad uses. And with things like pain medicines, it gets complicated because there are so many compounding factors. (Yes, they are prescribed too much, but we need more than tight controls on one drug class).

Guidelines | FAQ | Support | API | Security | Lists | Bookmarklet | Legal | Apply to YC | Contact